Editorial: let's get physical-long-term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease
- PMID: 36821747
- PMCID: PMC10026692
- DOI: 10.1111/apt.17336
Editorial: let's get physical-long-term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease
Conflict of interest statement
CONFLICT OF INTEREST
Dr Stine has received research funding from Astra Zeneca, Galectin, Grifols Inc, Noom Inc, Novo Nordisk and Zydus.
Comment on
-
Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD).Aliment Pharmacol Ther. 2023 Mar;57(6):709-722. doi: 10.1111/apt.17308. Epub 2022 Nov 15. Aliment Pharmacol Ther. 2023. PMID: 36380111
References
-
- Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, et al. 2019 Global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022;20:2809–17.e28. - PubMed
-
- Kim D, Murag S, Cholankeril G, Cheung A, Harrison SA, Younossi ZM, et al. Physical activity, measured objectively, is associated with lower mortality in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2021;19(6):1240–7.e5. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical